序贯器官衰竭评估评分与新引入标准Traumasis在交通事故伤患者中的评估
本研究回顾性纳入2017年1月至2018年12月连续收治于研究医院急诊科的成人交通事故伤患者927例,院内死亡46例(5.0%)。SOFA评分预测院内死亡的AUROC为0.91(95%CI 0.87-0.95),与TRISS的0.88(95%CI 0.84-0.93)相当,优于ISS的0.81(95%CI 0.75-0.86)和RTS的0.82(95%CI 0.75-0.90)。Traumasis标准(SOFA≥2)灵敏度95.7%、特异度63.0%、阳性预测值11.9%、阴性预测值99.6%。多因素Cox回归显示SOFA评分(aHR 1.52;95%CI 1.37-1.67)和Traumasis(aHR 11.40;95%CI 2.70-48.13)分别与更高的院内死亡率独立相关。作者认为SOFA评分可作为预测交通事故伤患者院内死亡的可靠工具,Traumasis标准可能用于创伤患者的风险分层和质量控制。
要点
- 927例交通事故伤患者中46例(5.0%)院内死亡,SOFA评分中位数1.0(IQR 0.0-3.0)。
- SOFA评分预测院内死亡的AUROC为0.91(95%CI 0.87-0.95),与TRISS的0.88(95%CI 0.84-0.93)相当,优于ISS的0.81(95%CI 0.75-0.86)和RTS的0.82(95%CI 0.75-0.90)。
- Traumasis(SOFA≥2)共417例(45.0%),其中44例死亡(10.6%);该标准灵敏度95.7%、特异度63.0%、阳性预测值11.9%、阴性预测值99.6%。
- Traumasis与主要创伤标准(ISS≥15)比较的净重分类改善为0.69(95%CI 0.55-0.82;P<0.001)。
- 多因素Cox回归显示SOFA评分(aHR 1.52;95%CI 1.37-1.67)和Traumasis(aHR 11.40;95%CI 2.70-48.13)分别与更高的院内死亡率独立相关。
适用人群与场景
- 连续收治于研究医院急诊科的成人交通事故伤患者,纳入时间为2017年1月至2018年12月,回顾性纳入。
诊断标准与关键阈值
- Traumasis标准定义为创伤患者SOFA评分≥2分。
- SOFA评分使用急诊科初始相关数据计算。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入927例成人交通事故伤患者,其中46例(5.0%)院内死亡。
- SOFA评分中位数1.0(IQR 0.0-3.0);Traumasis(SOFA≥2)417例(45.0%),其中44例死亡(10.6%)。
- 主要终点院内死亡的AUROC:SOFA评分0.91(95%CI 0.87-0.95),TRISS 0.88(95%CI 0.84-0.93),ISS 0.81(95%CI 0.75-0.86),RTS 0.82(95%CI 0.75-0.90)。
- Traumasis标准预测院内死亡的灵敏度95.7%、特异度63.0%、阳性预测值11.9%、阴性预测值99.6%。
- Traumasis与主要创伤标准(ISS≥15)比较的净重分类改善为0.69(95%CI 0.55-0.82;P<0.001)。
- 多因素Cox回归显示SOFA评分(aHR 1.52;95%CI 1.37-1.67)和Traumasis(aHR 11.40;95%CI 2.70-48.13)分别与更高的院内死亡率独立相关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为SOFA评分可作为预测交通事故伤患者院内死亡的可靠工具。
- 作者认为新引入的Traumasis标准可能作为创伤患者的风险分层和质量控制标准,类似于感染性疾病患者的脓毒症标准。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The aim of this study was to evaluate the performance of the Sequential Organ Failure Assessment (SOFA) score and the newly introduced criteria, traumasis, defined as a SOFA score 2 or more among trauma patients.
METHODS: Consecutive adult traffic collision patients who were admitted to the study hospital emergency department (ED) from January 2017 to December 2018 were enrolled retrospectively in the study. The primary outcome was in-hospital death. The SOFA score was calculated using relevant initial ED data. Traditional risk scores for trauma patients, such as the injury severity score (ISS), the revised trauma score (RTS), and the trauma injury severity score (TRISS), were also calculated.
RESULTS: A total of 927 patients were available for analysis, of whom 46 died (5.0%). The median SOFA score was 1.0 (interquartile range [IQR], 0.0-3.0). A total of 417 patients (45.0%) were identified as having traumasis (SOFA score ≥ 2), of whom 44 died (10.6%). The area under the receiver operating characteristic (AUROC) curve of the SOFA score (0.91; 95% confidence interval [CI] 0.87-0.95) was comparable with that of the TRISS (0.88; 95% CI, 0.84-0.93) and better than that of the ISS(0.81; 95% CI 0.75-0.86) and the RTS (0.82; 95% CI 0.75-0.90). The sensitivity, specificity, positive predictive value and negative predictive value of the traumasis criteria for the primary outcome were 95.7%, 63.0%, 11.9%, and 99.6%, respectively. The net reclassification improvement for the comparison between the traumasis criteria and major trauma criteria (ISS ≥ 15) was 0.69 (95% CI, 0.55-0.82; p < 0.001). The multivariate Cox regression model showed that the SOFA score (adjusted hazard ratio [aHR] 1.52; 95% CI 1.37-1.67) and traumasis (aHR 11.40; 95% CI 2.70-48.13), respectively, was independently associated with higher in-hospital mortality.
CONCLUSION: The SOFA score can be used as a reliable tool for predicting in-hospital death among traffic collision patients. The newly introduced criteria, traumasis, may be used as a risk-stratification and quality-control criteria among patients with trauma, similar to the sepsis criteria among patients with infectious disease.
参考来源
- Jo S, Jeong T, Park B, et al. Evaluation of the sequential organ failure assessment score and newly introduced criteria - Traumasis - in traffic collision patients. Am J Emerg Med. 2021. PMID: 34717212. doi:10.1016/j.ajem.2021.10.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。